Structural rearrangements allow nucleic acid discrimination by type I-D Cascade.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
20 05 2022
Historique:
received: 04 10 2021
accepted: 27 04 2022
entrez: 20 5 2022
pubmed: 21 5 2022
medline: 25 5 2022
Statut: epublish

Résumé

CRISPR-Cas systems are adaptive immune systems that protect prokaryotes from foreign nucleic acids, such as bacteriophages. Two of the most prevalent CRISPR-Cas systems include type I and type III. Interestingly, the type I-D interference proteins contain characteristic features of both type I and type III systems. Here, we present the structures of type I-D Cascade bound to both a double-stranded (ds)DNA and a single-stranded (ss)RNA target at 2.9 and 3.1 Å, respectively. We show that type I-D Cascade is capable of specifically binding ssRNA and reveal how PAM recognition of dsDNA targets initiates long-range structural rearrangements that likely primes Cas10d for Cas3' binding and subsequent non-target strand DNA cleavage. These structures allow us to model how binding of the anti-CRISPR protein AcrID1 likely blocks target dsDNA binding via competitive inhibition of the DNA substrate engagement with the Cas10d active site. This work elucidates the unique mechanisms used by type I-D Cascade for discrimination of single-stranded and double stranded targets. Thus, our data supports a model for the hybrid nature of this complex with features of type III and type I systems.

Identifiants

pubmed: 35595728
doi: 10.1038/s41467-022-30402-8
pii: 10.1038/s41467-022-30402-8
pmc: PMC9123187
doi:

Substances chimiques

CRISPR-Associated Proteins 0
Nucleic Acids 0
RNA 63231-63-0
DNA 9007-49-2

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2829

Subventions

Organisme : NIGMS NIH HHS
ID : R35 GM138348
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007392
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

Hampton, H. G., Watson, B. N. J. & Fineran, P. C. The arms race between bacteria and their phage foes. Nature 577, 327–336 (2020).
pubmed: 31942051 doi: 10.1038/s41586-019-1894-8
Hille, F. et al. The biology of CRISPR-Cas: backward and forward. Cell 172, 1239–1259 (2018).
pubmed: 29522745 doi: 10.1016/j.cell.2017.11.032
Barrangou, R. et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315, 1709–1712 (2007).
pubmed: 17379808 doi: 10.1126/science.1138140
Jackson, S. A. et al. CRISPR-Cas: adapting to change. Science 356, eaal5056 (2017).
Nishimasu, H. & Nureki, O. Structures and mechanisms of CRISPR RNA-guided effector nucleases. Curr. Opin. Struct. Biol. 43, 68–78 (2017).
pubmed: 27912110 doi: 10.1016/j.sbi.2016.11.013
Makarova, K. S. et al. Evolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants. Nat. Rev. Microbiol. 18, 67–83 (2020).
pubmed: 31857715 doi: 10.1038/s41579-019-0299-x
Makarova, K. S. et al. An updated evolutionary classification of CRISPR-Cas systems. Nat. Rev. Microbiol. 13, 722–736 (2015).
pubmed: 26411297 pmcid: 5426118 doi: 10.1038/nrmicro3569
Slaymaker, I. M. & Gaudelli, N. M. Engineering Cas9 for human genome editing. Curr. Opin. Struct. Biol. 69, 86–98 (2021).
pubmed: 33964614 doi: 10.1016/j.sbi.2021.03.004
Bravo, J. P. K., Liu, M., Mccool, R. S. & Jung, K. Structural basis for mismatch surveillance by CRISPR/Cas9. Nature 603, 343–347 (2022).
pubmed: 35236982 pmcid: 8907077 doi: 10.1038/s41586-022-04470-1
Cameron, P. et al. Harnessing type I CRISPR–Cas systems for genome engineering in human cells. Nat. Biotechnol. 37, 1471–1477 (2019).
pubmed: 31740839 doi: 10.1038/s41587-019-0310-0
Csörgő, B. et al. A compact Cascade–Cas3 system for targeted genome engineering. Nat. Methods 17, 1183–1190 (2020).
pubmed: 33077967 pmcid: 7611934 doi: 10.1038/s41592-020-00980-w
Osakabe, K. et al. Genome editing in plants using CRISPR type I-D nuclease. Commun. Biol. 3, 648 (2020).
Dillard, K. E. et al. Assembly and translocation of a CRISPR-Cas primed acquisition complex. Cell 175, 934.e15–946.e15 (2018).
doi: 10.1016/j.cell.2018.09.039
Jore, M. M. et al. Structural basis for CRISPR RNA-guided DNA recognition by Cascade. Nat. Struct. Mol. Biol. 18, 529–536 (2011).
pubmed: 21460843 doi: 10.1038/nsmb.2019
Hochstrasser, M. L. et al. CasA mediates Cas3-catalyzed target degradation during CRISPR RNA-guided interference. Proc. Natl Acad. Sci. USA 111, 6618–6623 (2014).
pubmed: 24748111 pmcid: 4020112 doi: 10.1073/pnas.1405079111
Westra, E. R. et al. CRISPR immunity relies on the consecutive binding and degradation of negatively supercoiled invader DNA by Cascade and Cas3. Mol. Cell 46, 595–605 (2012).
pubmed: 22521689 pmcid: 3372689 doi: 10.1016/j.molcel.2012.03.018
Xiao, Y., Luo, M., Dolan, A. E., Liao, M. & Ke, A. Structure basis for RNA-guided DNA degradation by Cascade and Cas3. Science 361, eaat0839 (2018).
Goldberg, G. W., Jiang, W., Bikard, D. & Marraffini, L. A. Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting. Nature 514, 633–637 (2014).
pubmed: 25174707 pmcid: 4214910 doi: 10.1038/nature13637
Jia, N. et al. Type III-A CRISPR-Cas Csm complexes: assembly, periodic RNA cleavage, DNase activity regulation, and autoimmunity. Mol. Cell 73, 264.e5–277.e5 (2019).
doi: 10.1016/j.molcel.2018.11.007
Samai, P. et al. Co-transcriptional DNA and RNA cleavage during type III CRISPR-cas immunity. Cell 161, 1164–1174 (2015).
pubmed: 25959775 pmcid: 4594840 doi: 10.1016/j.cell.2015.04.027
Wang, L. et al. Dynamics of Cas10 govern discrimination between self and non-self in type III CRISPR-Cas immunity. Mol. Cell 73, 278–290.e4 (2019).
pubmed: 30503774 doi: 10.1016/j.molcel.2018.11.008
Niewoehner, O. et al. Type III CRISPR-Cas systems produce cyclic oligoadenylate second messengers. Nature 548, 543–548 (2017).
pubmed: 28722012 doi: 10.1038/nature23467
Kazlauskiene, M., Kostiuk, G., Venclovas, Č., Tamulaitis, G. & Siksnys, V. A. cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems. Science 357, 605–609 (2017).
pubmed: 28663439 doi: 10.1126/science.aao0100
Makarova, K. S., Wolf, Y. I., Snir, S. & Koonin, E. V. Defense islands in bacterial and archaeal genomes and prediction of novel defense systems. J. Bacteriol. 193, 6039–6056 (2011).
pubmed: 21908672 pmcid: 3194920 doi: 10.1128/JB.05535-11
McBride, T. M. et al. Diverse CRISPR-Cas complexes require independent translation of small and large subunits from a single gene. Mol. Cell 80, 971–9 e7 (2020).
pubmed: 33248026 doi: 10.1016/j.molcel.2020.11.003
Sofos, N. et al. Structures of the Cmr-β complex reveal the regulation of the immunity mechanism of type III-B CRISPR-Cas. Mol. Cell 79, 741.e7–757.e7 (2020).
doi: 10.1016/j.molcel.2020.07.008
Steens, J. A. et al. SCOPE enables type III CRISPR-Cas diagnostics using flexible targeting and stringent CARF ribonuclease activation. Nat. Commun. 12, 5033 (2021).
pubmed: 34413302 pmcid: 8376896 doi: 10.1038/s41467-021-25337-5
Manav, M. C. et al. Structural basis for inhibition of an archaeal CRISPR–Cas type I-D large subunit by an anti-CRISPR protein. Nat. Commun. 11, 5993 (2020).
pubmed: 33239638 pmcid: 7689449 doi: 10.1038/s41467-020-19847-x
Kieper, S. N. et al. Cas4 facilitates PAM-compatible spacer selection during CRISPR adaptation. Cell Rep. 22, 3377–3384 (2018).
pubmed: 29590607 pmcid: 5896167 doi: 10.1016/j.celrep.2018.02.103
Shah, S. A., Erdmann, S., Mojica, F. J. M. & Garrett, R. A. Protospacer recognition motifs: mixed identities and functional diversity. RNA Biol. 10, 891–899 (2013).
pubmed: 23403393 pmcid: 3737346 doi: 10.4161/rna.23764
O’Brien, R. E. et al. Structural basis for assembly of non-canonical small subunits into type I-C Cascade. Nat. Commun. 11, 5931 (2020).
pubmed: 33230133 pmcid: 7684278 doi: 10.1038/s41467-020-19785-8
Jackson, R. N. et al. Structural biology. Crystal structure of the CRISPR RNA-guided surveillance complex from Escherichia coli. Science 345, 1473–1479 (2014).
pubmed: 25103409 pmcid: 4188430 doi: 10.1126/science.1256328
Chowdhury, S. et al. Structure reveals mechanisms of viral suppressors that intercept a CRISPR RNA-guided surveillance complex. Cell 169, 47.e11–57.e11 (2017).
doi: 10.1016/j.cell.2017.03.012
Lin, J. et al. DNA targeting by subtype I-D CRISPR-Cas shows type i and type III features. Nucleic Acids Res. 48, 10470–10478 (2020).
pubmed: 32960267 pmcid: 7544194 doi: 10.1093/nar/gkaa749
Vink, J. N. A., Baijens, J. H. L. & Brouns, S. J. J. PAM-repeat associations and spacer selection preferences in single and co-occurring CRISPR-Cas systems. Genome Biol. 22, 281 (2021).
Zhou, Y. et al. Structure of a type IV CRISPR-Cas ribonucleoprotein complex. iScience 24, 102201 (2021).
pubmed: 33733066 pmcid: 7937560 doi: 10.1016/j.isci.2021.102201
Hayes, R. P. et al. Structural basis for promiscuous PAM recognition in type I-E Cascade from E. coli. Nature 530, 499–503 (2016).
pubmed: 26863189 pmcid: 5134256 doi: 10.1038/nature16995
Liu, M. et al. Engineered CRISPR/Cas9 enzymes improve discrimination by slowing DNA cleavage to allow release of off-target DNA. Nat. Commun. 11, 1–13 (2020).
Bravo, J. P. K. et al. Structural basis of rotavirus RNA chaperone displacement and RNA annealing. Proc. Natl Acad. Sci. USA 41, e2100198118 (2021).
doi: 10.1073/pnas.2100198118
Staals, R. H. J. et al. RNA targeting by the type III-A CRISPR-Cas Csm complex of Thermus thermophilus. Mol. Cell 56, 518–530 (2014).
pubmed: 25457165 pmcid: 4342149 doi: 10.1016/j.molcel.2014.10.005
Osawa, T., Inanaga, H., Sato, C. & Numata, T. Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog. Mol. Cell 58, 418–430 (2015).
pubmed: 25921071 doi: 10.1016/j.molcel.2015.03.018
Taylor, D. W. et al. Structure of the CRISPR-Cmr complex reveal mode of RNA target positioning. Science 348, 581–586 (2015).
pubmed: 25837515 pmcid: 4582657 doi: 10.1126/science.aaa4535
Hrle, A. et al. Structural analyses of the CRISPR protein Csc2 reveal the RNA-binding interface of the type I-D Cas7 family. RNA Biol. 11, 1072–1082 (2014).
pubmed: 25483036 pmcid: 4615900 doi: 10.4161/rna.29893
You, L. et al. Structure studies of the CRISPR-Csm complex reveal mechanism of co-transcriptional interference. Cell 176, 239.e16–253.e16 (2019).
doi: 10.1016/j.cell.2018.10.052
Estrella, M. A., Kuo, F. T. & Bailey, S. RNA-activated DNA cleavage by the Type III-B CRISPR–Cas effector complex. Genes Dev. 30, 460–470 (2016).
pubmed: 26848046 pmcid: 4762430 doi: 10.1101/gad.273722.115
Bernheim, A. et al. Prokaryotic viperins produce diverse antiviral molecules. Nature 589, 120–124 (2020).
pubmed: 32937646 pmcid: 7610908 doi: 10.1038/s41586-020-2762-2
Redding, S. et al. Surveillance and processing of foreign DNA by the Escherichia coli CRISPR-Cas system. Cell 163, 854–865 (2015).
pubmed: 26522594 pmcid: 4636941 doi: 10.1016/j.cell.2015.10.003
Tompa, P. & Csermely, P. The role of structural disorder in the function of RNA and protein chaperones. FASEB J. 18, 1169–1175 (2004).
pubmed: 15284216 doi: 10.1096/fj.04-1584rev
Bravo, J. P. K. et al. Stability of local secondary structure determines selectivity of viral RNA chaperones. Nucleic Acids Res. 46, 7924–7937 (2018).
pubmed: 29796667 pmcid: 6125681 doi: 10.1093/nar/gky394
Donlin, M. J., Patel, S. S. & Johnson, K. A. Kinetic partitioning between the exonuclease and polymerase sites in DNA error correction. Biochemistry 30, 538–546 (1991).
pubmed: 1988042 doi: 10.1021/bi00216a031
Thirumalai, D. & Woodson, S. A. Kinetics of folding of proteins and RNA. Acc. Chem. Res. 29, 433–439 (1996).
doi: 10.1021/ar9500933
Suloway, C. et al. Automated molecular microscopy: the new Leginon system. J. Struct. Biol. 151, 41–60 (2005).
Tegunov, D. & Cramer, P. Real-time cryo-electron microscopy data preprocessing with Warp. Nat. Methods 16, 1146–1152 (2019).
pubmed: 31591575 pmcid: 6858868 doi: 10.1038/s41592-019-0580-y
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. CryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
pubmed: 28165473 doi: 10.1038/nmeth.4169
Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214–1221 (2020).
pubmed: 33257830 doi: 10.1038/s41592-020-00990-8
Zivanov, J. et al. RELION-3: new tools for automated high-resolution cryo-EM structure determination. Elife 7, 421123 (2018).
Sanchez-Garcia, R. et al. DeepEMhancer: a deep learning solution for cryo-EM volume post-processing. Commun. Biol. 4, 874 (2021).
pubmed: 34267316 pmcid: 8282847 doi: 10.1038/s42003-021-02399-1
Kelley, L. A., Mezulis, S., Yates, C. M., Wass, M. N. & Sternberg, M. J. The Phyre2 web portal for protein modeling, prediction and analysis. Nat. Protoc. 10, 845–858 (2016).
doi: 10.1038/nprot.2015.053
Buchan, D. W. A. & Jones, D. T. The PSIPRED Protein Analysis Workbench: 20 years on. Nucleic Acids Res. 47, W402–W407 (2019).
pubmed: 31251384 pmcid: 6602445 doi: 10.1093/nar/gkz297
Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. Sect. D Biol. Crystallogr. 60, 2126–2132 (2004).
doi: 10.1107/S0907444904019158
Croll, T. I. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr. Sect. D 74, 519–530 (2018).
doi: 10.1107/S2059798318002425
Goddard, T. D. et al. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 27, 14–25 (2018).
pubmed: 28710774 doi: 10.1002/pro.3235
Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70–82 (2021).
pubmed: 32881101 doi: 10.1002/pro.3943
Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. Sect. D Struct. Biol. 74, 531–544 (2018).
doi: 10.1107/S2059798318006551
Kidmose, R. T. et al. Namdinator - automatic molecular dynamics flexible fitting of structural models into cryo-EM and crystallography experimental maps. IUCrJ 6, 526–531 (2019).
pubmed: 31316797 pmcid: 6608625 doi: 10.1107/S2052252519007619
Morin, A. et al. Collaboration gets the most out of software. Elife 2013, 1–6 (2013).
Ashkenazy, H. et al. ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules. Nucleic Acids Res. 44, W344–W350 (2016).
pubmed: 27166375 pmcid: 4987940 doi: 10.1093/nar/gkw408
Roy, A., Kucukural, A. & Zhang, Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nat. Protoc. 5, 725–738 (2010).
pubmed: 20360767 pmcid: 2849174 doi: 10.1038/nprot.2010.5
Di Tommaso, P. et al. T-Coffee: a web server for the multiple sequence alignment of protein and RNA sequences using structural information and homology extension. Nucleic Acids Res. 39, 13–17 (2011).
doi: 10.1093/nar/gkr245
Guzman, L. M., Belin, D., Carson, M. J. & Beckwith, J. Tight regulation, modulation, and high-level expression by vectors containing the arabinose P(BAD) promoter. J. Bacteriol. 177, 4121–4130 (1995).
pubmed: 7608087 pmcid: 177145 doi: 10.1128/jb.177.14.4121-4130.1995
Williams, J. G. K. Construction of specific mutations in photosystem II photosynthetic reaction center by genetic engineering methods in Synechocystis 6803. Methods Enzymol. 167, 766–778 (1988).
doi: 10.1016/0076-6879(88)67088-1
Morris, J. N. et al. Whole genome re-sequencing of two ‘wild-type’ strains of the model cyanobacterium Synechocystis sp. PCC 6803. N. Z. J. Bot. 52, 36–47 (2014).
doi: 10.1080/0028825X.2013.846267

Auteurs

Evan A Schwartz (EA)

Department of Molecular Biosciences, University of Texas at Austin, Austin, TX, 78712-1597, USA.
Interdiscplinary Life Sciences Graduate Programs, University of Texas at Austin, Austin, TX, 78712-1597, USA.

Tess M McBride (TM)

Microbiology and Immunology, University of Otago, PO Box 56, Dunedin, 9054, New Zealand.

Jack P K Bravo (JPK)

Department of Molecular Biosciences, University of Texas at Austin, Austin, TX, 78712-1597, USA.

Daniel Wrapp (D)

Department of Molecular Biosciences, University of Texas at Austin, Austin, TX, 78712-1597, USA.
Interdiscplinary Life Sciences Graduate Programs, University of Texas at Austin, Austin, TX, 78712-1597, USA.

Peter C Fineran (PC)

Microbiology and Immunology, University of Otago, PO Box 56, Dunedin, 9054, New Zealand.
Bioprotection Aotearoa, University of Otago, PO Box 56, Dunedin, 9054, New Zealand.
Genetics Otago, University of Otago, Dunedin, New Zealand.

Robert D Fagerlund (RD)

Microbiology and Immunology, University of Otago, PO Box 56, Dunedin, 9054, New Zealand.
Bioprotection Aotearoa, University of Otago, PO Box 56, Dunedin, 9054, New Zealand.
Genetics Otago, University of Otago, Dunedin, New Zealand.

David W Taylor (DW)

Department of Molecular Biosciences, University of Texas at Austin, Austin, TX, 78712-1597, USA. dtaylor@utexas.edu.
Interdiscplinary Life Sciences Graduate Programs, University of Texas at Austin, Austin, TX, 78712-1597, USA. dtaylor@utexas.edu.
Center for Systems and Synthetic Biology, University of Texas at Austin, Austin, TX, 78712-1597, USA. dtaylor@utexas.edu.
LIVESTRONG Cancer Institutes, Dell Medical School, Austin, TX, 78712-1597, USA. dtaylor@utexas.edu.

Articles similaires

Prader-Willi Syndrome Humans Angelman Syndrome CRISPR-Cas Systems Human Embryonic Stem Cells
Humans RNA, Circular Exosomes Cell Proliferation Epithelial-Mesenchymal Transition
DNA Methylation Humans DNA Animals Machine Learning
DNA Glycosylases Nucleosomes Humans 8-Hydroxy-2'-Deoxyguanosine DNA Repair

Classifications MeSH